Pituitary and ovarian suppression rate after high dosage of gonadotropin-releasing hormone agonist
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Fertility and Sterility
- Vol. 51 (4), 578-581
- https://doi.org/10.1016/s0015-0282(16)60602-7
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Induction of Ovulation in Primate ModelsEndocrine Reviews, 1986
- Comparison of the Potential for Therapeutic Utilities with Gonadotropin-Releasing Hormone Agonists and AntagonistsEndocrine Reviews, 1986
- Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppressionFertility and Sterility, 1986
- Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot studyAmerican Journal of Obstetrics and Gynecology, 1985
- Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophinsBJOG: An International Journal of Obstetrics and Gynaecology, 1985
- Regression of leiomyomata uteri following hypoestrogenism induced by repetitive luteinizing hormone-releasing hormone agonist treatment: preliminary reportFertility and Sterility, 1984
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- Clinical uses of luteinizing hormone-releasing hormoneFertility and Sterility, 1983
- Abortion rate in pregnancies following ovulation induced by human menopausal gonadotropin/human chorionic gonadotropinFertility and Sterility, 1983
- CLINICAL EFFECT OF HUMAN PITUITARY FOLLICLE-STIMULATING HORMONE (FSH)*Journal of Clinical Endocrinology & Metabolism, 1958